Composition
- Active ingredients
- PRALSETINIB 100MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- PRALSETINIB 100MG · CapsuleNDA213721-001 · Prescription
- PRALSETINIB 100MG · CapsuleThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA214701.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Gavreto
- Active substance
- pralsetinib
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Blueprint Medicines
- Status
- Prescription
- FDA approval
- 1 Dec 2020
- Application
- NDA214701-001